Ovarian Tumor 25

Embed Size (px)

Citation preview

  • 8/12/2019 Ovarian Tumor 25

    1/83

  • 8/12/2019 Ovarian Tumor 25

    2/83

    2

  • 8/12/2019 Ovarian Tumor 25

    3/83

    3

  • 8/12/2019 Ovarian Tumor 25

    4/83

    Ovaries

    4

    The most important medical problems in ovaries arethe neoplasms

    Death from ovarian cancers is more than that of

    cervix and uterus together

    Silent growth of ovarian tumors is the rule ,whichmake them so dangerous

  • 8/12/2019 Ovarian Tumor 25

    5/83

    Ovarian

    Cysts and Tumors

    5

    Non neoplastic cysts are common but they are notserious problems

    Primary inflammation of ovaries is rare

    Salpingitis of fallopian tubes frequently causesperiovarian reaction (salpingo-Oophoritis)

    Frequently ,the ovaries affected by endometriosis.

  • 8/12/2019 Ovarian Tumor 25

    6/83

    Non-Neoplastic and Functional Cysts of

    ovary

    6

    Non Neoplastic Cyst are more common than theneoplastic ones

    Follicular and Luteal cysts are most probably

    physiologic

    cystic follicles:Innocent lesions originate from

    unruptured follicles or in follicles that have

    ruptured and sealed. Usually they are small 1

    1.5 cm ,and filled by clear fluid

  • 8/12/2019 Ovarian Tumor 25

    7/83

    Follicular Cyst

    7

    Is due to distention of unruptured graafian follicle It is sometimes associated with hyperestrinism and

    endometrial hyperplasia.

  • 8/12/2019 Ovarian Tumor 25

    8/83

    Corpus luteum cyst

    8

    It results from hemorrhage into a persistent maturecorpus luteum.

  • 8/12/2019 Ovarian Tumor 25

    9/83

    Theca lutein cyst

    9

    Results from gonadotropin stimulation. Often multiple and bilateral.

  • 8/12/2019 Ovarian Tumor 25

    10/83

    Chocolate cyst

    10

    Is a blood containing cyst resulting from ovarianendometriosis with hemorrhage.

    The ovary is the most common site for

    endometriosis.

  • 8/12/2019 Ovarian Tumor 25

    11/83

    11

  • 8/12/2019 Ovarian Tumor 25

    12/83

    12

  • 8/12/2019 Ovarian Tumor 25

    13/83

    13

  • 8/12/2019 Ovarian Tumor 25

    14/83

    Polycystic Ovaries

    Stein-Leventhal Syndrome

    14

    Young women ,and usually in girls after menarche.-Oligomenorrhea

    -hirsutism

    -infertility

    -Obesity

  • 8/12/2019 Ovarian Tumor 25

    15/83

    Polycystic Ovaries

    Stein-Leventhal Syndrome

    15

    Secondary to excessive production of estrogens andandrogens, mainly androgens

    The ovaries are usually twice normal in size ,gray-

    white with smooth outer surface

    Studded with sub cortical cysts 0.5 to 1.5 cm indiameter.

    l

  • 8/12/2019 Ovarian Tumor 25

    16/83

    Polycystic Ovaries

    Stein-Leventhal Syndrome

    16

    Histologically ,thickened fibrosed outer tunica Multiple cysts lined by granulosa cells

    Absence of corpora lutea

    High level of LH and low FSH

  • 8/12/2019 Ovarian Tumor 25

    17/83

    17

  • 8/12/2019 Ovarian Tumor 25

    18/83

    18

    Figure 22-36 Polycystic ovarian disease and cortical stromal hyperplasia. A, The ovarian cortex reveals numerous clear cysts. B, Sectioning of the cortex reveals several

    subcortical cystic follicles. C, Cystic follicles seen in a low-power microphotograph. D, Cortical stromal hyperplasia manifests as diffuse stromal proliferation with

    symmetrical enlargement of the ovary.

    Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 28 April 2008 01:14 PM)

    2007 Elsevier

  • 8/12/2019 Ovarian Tumor 25

    19/83

    19

    Figure 22-36 Polycystic ovarian disease and cortical stromal hyperplasia. A, The ovarian cortex reveals numerous clear cysts. B, Sectioning of the cortex reveals several

    subcortical cystic follicles. C, Cystic follicles seen in a low-power microphotograph. D, Cortical stromal hyperplasia manifests as diffuse stromal proliferation with

    symmetrical enlargement of the ovary.

    Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 28 April 2008 01:14 PM)

    2007 Elsevier

  • 8/12/2019 Ovarian Tumor 25

    20/83

  • 8/12/2019 Ovarian Tumor 25

    21/83

    Ovarian Tumors

    21

    Fifth most common cancer in the USA Fifth leading cause of cancer death in women

    Diversity of pathologic entities because of the three

    cell types make up the normal ovary

  • 8/12/2019 Ovarian Tumor 25

    22/83

    Ovarian Tumors classification

    22

    Three cell types : 1- the surface epithelium tumors

    2- Germ cells tumors

    3- Stromal /sex cord cells tumors

  • 8/12/2019 Ovarian Tumor 25

    23/83

    23

    Figure 22-37 Derivation of various ovarian neoplasms and some data on their frequency and age distribution.

    Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 28 April 2008 01:14 PM)

    2007 Elsevier

    Cl ifi ti f O i T

  • 8/12/2019 Ovarian Tumor 25

    24/83

    Classification of Ovarian Tumors,

    Surface Epithelial Tumors

    24

    :-Serous Tumors : Benign ,Borderline,And

    malignant-Mucinous T. : Benign ,Borderline , and malignant-Endometrioid T. : Benign, Borderline, and

    malignant-Transitional cell T. :Brenner tumors, Benign ,Borderline ,and malignant-Undifferentiated Carcinoma

  • 8/12/2019 Ovarian Tumor 25

    25/83

    Classification of Ovarian Tumors,Sex Cord-Stromal tumors

    25

    - -Granulosa Cell tuomr- -ThecomaFibroma

    - -Sertoli-Leydig cell tumor

    - -Gynandroblastoma

    - -Unclassified

  • 8/12/2019 Ovarian Tumor 25

    26/83

    Classification of Ovarian Tumors, Germ Cell

    Tumors

    26

    - -Dysgerminoma- -Yolk Sac Tumor

    - -Embryonal Carcinoma

    - -Choriocarcinoma

    - -Teratoma : Mature, Immature

    - -Polyembryoma

  • 8/12/2019 Ovarian Tumor 25

    27/83

    O arian Tumors

  • 8/12/2019 Ovarian Tumor 25

    28/83

    Ovarian Tumors

    Surface Epithelium Origin

    28

    Neoplasms of surface epithelium account for the

    great majority of all primary ovarian tumors.

    Ovarian Tumors

  • 8/12/2019 Ovarian Tumor 25

    29/83

    Ovarian Tumors ,

    Surface Epithelium Origin

    29

    6570 % of overall tumors

    90 % of malignant tumors

    Age 20+

    Traditionally divided into Benign ,Malignant ,and

    Borderline in malignancy Can be strictly epithelial (serous ,Mucinous)

    Ovarian Tumors

  • 8/12/2019 Ovarian Tumor 25

    30/83

    Ovarian Tumors ,

    Surface Epithelium Origin

    30

    Can have stromal component (Cystadenofibroma ,

    Brenner tumor )

    Ovarian Tumors

  • 8/12/2019 Ovarian Tumor 25

    31/83

    Ovarian Tumors ,

    Surface Epithelium Origin

    31

    The intermediate ,or the borderline tumors are

    referred as tumors of low malignant potential

    These appear to be low grade cancers with limited

    invasive potential

    They have better prognosis

  • 8/12/2019 Ovarian Tumor 25

    32/83

    Serous Tumors

    32

    The most frequent ovarian tumor

    Age is 30 -40

    May be solid ,usually cystic

    Cystadenoma or Cystadenofibroma

    65% benign ,15% low malignant potential , and 25%malignant

    65 % of all ovarian cancers

  • 8/12/2019 Ovarian Tumor 25

    33/83

    Serous Tumors

    33

    Most are large ,spherical to ovoid ,cystic structures

    510 cm and might be 30-40 cm

    25% of benign tumors are bilateral

    The surface of the benign is smooth and glistening

    .In contrast to the malignant forms ,the surface isnodular and irregular

  • 8/12/2019 Ovarian Tumor 25

    34/83

    Serous Tumors

    34

    Cystic spaces are filled by serous fluide Papillary formation is very important and need to

    be sampled well

    Histologically the benign tumors are lined by a

    single layer of tall columnar epithelium

    Papillary formation can be seen in both the

    benign and the malignant ones

  • 8/12/2019 Ovarian Tumor 25

    35/83

    Serous Tumors

    35

    Psammoma bodies could be seen

    Between the clearly benign and the solid malignanttumors we can see the tumors of low malignantpotential

    LMP tumors may seed the peritoneum, the implants

    of tumors are non invasive. Sometimes may behaveas invasive peritoneal implants

  • 8/12/2019 Ovarian Tumor 25

    36/83

    Serous Tumors

    36

    The prognosis of LMP tumors is determined mainly

    by the nature of the peritoneal implants

    Prognosis of invasive Serous cystadenocarcinoma

    after surgery ,chemotherapy ,and radiation is poor

    and depend on stage 70% 5year survival for the tumors confined to the

    ovary

  • 8/12/2019 Ovarian Tumor 25

    37/83

    Serous Tumors

    37

    5 year survival f0r LMP is 100% ,

    Malignant Tumors with capsular invasion ,survival for

    10 years is 13%

    LMP with capsular invasion the 10 year survival is

    80%.

  • 8/12/2019 Ovarian Tumor 25

    38/83

    38

  • 8/12/2019 Ovarian Tumor 25

    39/83

    39

  • 8/12/2019 Ovarian Tumor 25

    40/83

    40

  • 8/12/2019 Ovarian Tumor 25

    41/83

    41

  • 8/12/2019 Ovarian Tumor 25

    42/83

    42

  • 8/12/2019 Ovarian Tumor 25

    43/83

    43

  • 8/12/2019 Ovarian Tumor 25

    44/83

    44

  • 8/12/2019 Ovarian Tumor 25

    45/83

    45

    Figure 22-39 A, Borderline serous cystadenoma opened to display a cyst cavity lined by delicate papillary tumor growths. B, Cystadenocarcinoma. The cyst is opened to

    reveal a large, bulky tumor mass. C, Another borderline tumor growing on the ovarian surface (lower).

    Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 28 April 2008 01:14 PM)

    2007 Elsevier

  • 8/12/2019 Ovarian Tumor 25

    46/83

    46

    Figure 22-39 A, Borderline serous cystadenoma opened to display a cyst cavity lined by delicate papillary tumor growths. B, Cystadenocarcinoma. The cyst is opened to

    reveal a large, bulky tumor mass. C, Another borderline tumor growing on the ovarian surface (lower).

    Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 28 April 2008 01:14 PM)

    2007 Elsevier

  • 8/12/2019 Ovarian Tumor 25

    47/83

    47

    Figure 22-40 Papillary serous cystadenoma revealing stromal papillae with a columnar epithelium.

    Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 28 April 2008 01:14 PM)

    2007 Elsevier

  • 8/12/2019 Ovarian Tumor 25

    48/83

    48

    Figure 22-41 Borderline serous cystadenoma exhibiting increased architectural complexity and epithelial cell stratification.

    Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 28 April 2008 01:14 PM)

    2007 Elsevier

  • 8/12/2019 Ovarian Tumor 25

    49/83

    49

  • 8/12/2019 Ovarian Tumor 25

    50/83

    50

    Figure 22-42 Papillary serous cystadenocarcinoma of the ovary with invasion of underlying stroma.

    Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 28 April 2008 01:14 PM)

    2007 Elsevier

  • 8/12/2019 Ovarian Tumor 25

    51/83

    51

  • 8/12/2019 Ovarian Tumor 25

    52/83

    52

  • 8/12/2019 Ovarian Tumor 25

    53/83

    53

  • 8/12/2019 Ovarian Tumor 25

    54/83

    54

  • 8/12/2019 Ovarian Tumor 25

    55/83

    Mucinous Tumors

    55

    Epithelium is consists of mucin-producing cells

    Less likely to be malignant

    10% of ovarian cancers

    80% of them benign

    10% LMP

    10% malignant

  • 8/12/2019 Ovarian Tumor 25

    56/83

    56

    Figure 22-44 A, A mucinous cystadenoma with its multicystic appearance and delicate septa. Note the presence of glistening mucin within the cysts. B, Columnar cell

    lining of mucinous cystadenoma.

    Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 28 April 2008 01:14 PM)

    2007 Elsevier

  • 8/12/2019 Ovarian Tumor 25

    57/83

    57

  • 8/12/2019 Ovarian Tumor 25

    58/83

    Brenner Tumor

    58

    Transitional cell epithelium

    Most are benign

  • 8/12/2019 Ovarian Tumor 25

    59/83

    59

  • 8/12/2019 Ovarian Tumor 25

    60/83

    60

  • 8/12/2019 Ovarian Tumor 25

    61/83

    61

    Figure 22-46 A, Brenner tumor (right) associated with a benign cystic teratoma (left). B, Histologic detail of characteristic epithelial nests within the ovarian stroma.

    (Courtesy of Dr. M. Nucci, Brigham and Women's Hospital, Boston, MA.)

    Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 28 April 2008 01:14 PM)

    2007 Elsevier

  • 8/12/2019 Ovarian Tumor 25

    62/83

  • 8/12/2019 Ovarian Tumor 25

    63/83

  • 8/12/2019 Ovarian Tumor 25

    64/83

    64

    Sex Cord Tumors,

  • 8/12/2019 Ovarian Tumor 25

    65/83

    Sex Cord Tumors,

    Thecoma-Fibroma

    65

    Any age

    Unilateral

    Solid gray to yellow

    Rarely malignant

  • 8/12/2019 Ovarian Tumor 25

    66/83

    66

    Sex Cord Tumors

  • 8/12/2019 Ovarian Tumor 25

    67/83

    Sertoli - Leydig

    67

    All ages

    Unilateral Gray to yellow

    Produce androgens

    Uncommonly malignant

  • 8/12/2019 Ovarian Tumor 25

    68/83

    68

    Germ Cell Tumors

  • 8/12/2019 Ovarian Tumor 25

    69/83

    Dysgerminoma

    69

    2ndand 3rddecades

    Unilateral

    Counterpart to Seminoma

    Solid ,gray to yellow

    All malignant PLAP positive

  • 8/12/2019 Ovarian Tumor 25

    70/83

    70

  • 8/12/2019 Ovarian Tumor 25

    71/83

    Embryonal carcinoma

    71

    2ndand 3rddecade

    Solid

    Aggressive

    CD 30 positive.

    Germ Cell Tumors

  • 8/12/2019 Ovarian Tumor 25

    72/83

    Teratoma

    72

    15-20 % of Ovarian tumors

    Majority in the first 2 decades

    The younger the patient ,the greater the likelihood ofmalignancy

    Over 90% are benign cystic ,mature teratomas

    Immature teratomas are malignant and are rare.

  • 8/12/2019 Ovarian Tumor 25

    73/83

    73

  • 8/12/2019 Ovarian Tumor 25

    74/83

    74

    Figure 22-48 Opened mature cystic teratoma (dermoid cyst) of the ovary. Hair (bottom) and a mixture of tissues are evident.

    Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 28 April 2008 01:14 PM)

    2007 Elsevier

  • 8/12/2019 Ovarian Tumor 25

    75/83

    75

  • 8/12/2019 Ovarian Tumor 25

    76/83

    76

  • 8/12/2019 Ovarian Tumor 25

    77/83

    77

  • 8/12/2019 Ovarian Tumor 25

    78/83

    78

    Figure 22-49 Benign cystic teratoma. Low-power view of skin (top), beneath which there is brain tissue (bottom).

    Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 28 April 2008 01:14 PM)

    2007 Elsevier

  • 8/12/2019 Ovarian Tumor 25

    79/83

    Endodermal Sinus (Yolk Sac) Tumor

    79

    the tumor is rich in -fetoprotein and 1-antitrypsin.

    Its characteristic histologic feature is a glomerulus-likestructure composed of a central blood vessel envelopedby germ cells within a space lined by germ cells (Schiller-Duval body)

    stained for -fetoprotein by immunoperoxidase

    techniques Most patients are children or young women presenting

    with abdominal pain and a rapidly developing pelvicmass. The tumors usually appear to involve a singleovary but grow rapidly and aggressively.

  • 8/12/2019 Ovarian Tumor 25

    80/83

  • 8/12/2019 Ovarian Tumor 25

    81/83

    Choriocarcinoma

    81

    More commonly of placental origin, the choriocarcinoma,

    similar to the Most ovarian choriocarcinomas exist in combination with

    other germ cell tumors, and pure choriocarcinomas areextremely rare.

    are aggressive tumors that generally have metastasized

    widely through the bloodstream to the lungs, liver, bone,and other viscera by the time of diagnosis.

    high levels of chorionic gonadotropins that aresometimes helpful in establishing the diagnosis ordetecting recurrences.

    Ovarian Tumors

  • 8/12/2019 Ovarian Tumor 25

    82/83

    Metastatic Carcinoma

    82

    Older ages

    Mostly Bilateral

    Primaries are Breast ,lung, and G.I.T. (Krukenberg

    Tumors)

  • 8/12/2019 Ovarian Tumor 25

    83/83